English: The points on staff capacity we've discussed in answer to a previous question on work that is already under way, about the fact that our diagnostic capacity is showing an increase, an that there's an improvement in waiting times for people here in Wales. We've also discussed what we're doing to improve outcomes in answer to the question raised by your colleague David Melding. I'm looking to improve bowel testing and screening uptake. And actually, the biggest challenge there is getting the public to undertake the screening test themselves. That's why we're going to introduce a more effective and more sensitive test in January next year. So, we are already taking steps and, actually, when you look at our rates compared to the rest of the UK, we actually compare pretty well in terms of cancer outcomes. In terms of cancer waits, we could talk at length about the fact that we generally have a better performance on cancer waits in Wales than in England and, actually, our direct survival rates are directly comparable with England. When they have a more advantaged and wealthier population as a whole, you would actually expect their outcomes to be better. But the real challenge for us is not just to say that we compare well with England and the rest of the UK; the real challenge for us here in Wales is that every nation in the UK is at the wrong end of the survival table across Europe. Our ambition is not to continue to maintain a gap positively with England, but to do much better so that more people survive cancer after one year and five years, and when we're looking at our comparators in Europe, we can be much happier about where we are, and then again reset our sights on the next stage of improvement.
Welsh: Rydym wedi trafod y pwyntiau ar gapasiti staff mewn ateb i gwestiwn blaenorol ar y gwaith sydd eisoes ar y gweill, am y ffaith bod ein capasiti diagnostig yn dangos cynnydd, a bod amseroedd aros i bobl yma yng Nghymru yn gwella. Rydym hefyd wedi trafod beth a wnawn i wella canlyniadau mewn ateb i'r cwestiwn a ofynnodd eich cyd-Aelod, David Melding. Rwy'n anelu i wella profion canser y coluddyn a chynyddu'r nifer sy'n manteisio ar y prawf sgrinio. Ac mewn gwirionedd, yr her fwyaf yw cael y cyhoedd i fanteisio ar y prawf sgrinio eu hunain. Dyna pam y bwriadwn gyflwyno prawf mwy effeithiol a mwy sensitif ym mis Ionawr y flwyddyn nesaf. Felly, rydym eisoes yn rhoi camau ar waith a phan edrychwch ar ein cyfraddau o'u cymharu â gweddill y DU, rydym yn cymharu'n eithaf da o ran canlyniadau canser mewn gwirionedd. O ran amseroedd aros canser, gallasem gael sgwrs hir am y ffaith ein bod, yn gyffredinol, yn perfformio'n well yng Nghymru nag yn Lloegr mewn perthynas ag amseroedd aros canser ac mewn gwirionedd, mae ein cyfraddau goroesi uniongyrchol yn cymharu'n uniongyrchol â rhai Lloegr. O ystyried bod ganddynt boblogaeth fwy breintiedig a chyfoethocach yn gyffredinol, byddech yn disgwyl i'w canlyniadau fod yn well mewn gwirionedd. Ond nid dweud ein bod yn cymharu'n dda â Lloegr a gweddill y DU yw'r her go iawn i ni; yr her go iawn i ni yma yng Nghymru yw bod pob gwlad yn y DU ar y pen anghywir i'r tabl goroesi ar draws Ewrop. Nid parhau i gynnal bwlch cadarnhaol â Lloegr yw ein huchelgais, ond gwneud yn llawer gwell fel bod mwy o bobl yn goroesi canser ar ôl blwyddyn a phum mlynedd, a phan edrychwn ar ein cymaryddion yn Ewrop, gallwn fod yn llawer hapusach ynglŷn â'n sefyllfa, cyn troi ein golygon at y cam nesaf o welliant.